Description
Tirzepatide 5mg (Mounjaro
) is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes, working through dual action on GIP and GLP-1 receptors. It is typically prescribed after an initial 2.5mg dose and is part of a structured dose escalation plan.
Reviews
There are no reviews yet.